Texting your symptoms: a digital coach for cancer side effects?

NCT ID NCT07723495

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether a digital platform that sends symptom check-ins and self-care tips via text message can help people with head and neck or lung cancer report their health more consistently. Participants either receive standard symptom questionnaires or get extra monitoring and guidance for managing common side effects like dry mouth or shortness of breath. The goal is to see if this approach boosts symptom reporting and helps patients feel better during treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a digital platform (CIAS) that monitors additional symptoms and provides evidence-based self-management strategies via SMS text
What this could lead to
If it works, this approach could improve how cancer patients report symptoms and manage side effects, potentially leading to better quality of life and fewer unplanned hospital visits.
What could go wrong
This is a small, early-stage trial focused on feasibility and completion rates, not on clinical outcomes. The digital tool may not work for all patients, and the self-management handbook may not be effective for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT HEAD AND NECK NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Henry Ford Health

    Detroit, Michigan, 48202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.